Poolbeg Pharma lands deal with AI firm to pinpoint effective virus drugs
US giant OneThree Biotech will lend Open Orphan spinout its state-of-the-art technology to accelerate treatment of severe respiratory infection RSV
US giant OneThree Biotech will lend Open Orphan spinout its state-of-the-art technology to accelerate treatment of severe respiratory infection RSV